Diagnostic Utility of Exome Sequencing for Kidney Disease

Background: Exome sequencing is emerging as a first-line diagnostic method in some clinical disciplines, but its usefulness has yet to be examined for most constitutional disorders in adults, including chronic kidney disease, which affects more than 1 in 10 persons globally.

Methods: We conducted exome sequencing and diagnostic analysis in two cohorts totaling 3315 patients with chronic kidney disease. We assessed the diagnostic yield and, among the patients for whom detailed clinical data were available, the clinical implications of diagnostic and other medically relevant findings.

Results: In all, 3037 patients (91.6%) were over 21 years of age, and 1179 (35.6%) were of self-identified non-European ancestry. We detected diagnostic variants in 307 of the 3315 patients (9.3%), encompassing 66 different monogenic disorders. Of the disorders detected, 39 (59%) were found in only a single patient. Diagnostic variants were detected across all clinically defined categories, including congenital or cystic renal disease (127 of 531 patients [23.9%]) and nephropathy of unknown origin (48 of 281 patients [17.1%]). Of the 2187 patients assessed, 34 (1.6%) had genetic findings for medically actionable disorders that, although unrelated to their nephropathy, would also lead to subspecialty referral and inform renal management.

Conclusions: Exome sequencing in a combined cohort of more than 3000 patients with chronic kidney disease yielded a genetic diagnosis in just under 10% of cases. (Funded by the National Institutes of Health and others.).

Citing Articles

Genetic vs non-genetic kidney disease: prognosis insights from a multi-cohort study.

Dirim A, Torra R Clin Kidney J. 2025; 18(3):sfaf033.

PMID: 40046818 PMC: 11879448. DOI: 10.1093/ckj/sfaf033.

Hypertensive Emergency In UMOD-Related Autosomal Dominant Tubulointerstitial Kidney Disease.

Chaudhry T, Sapru S Brown J Hosp Med. 2025; 1(4):38580.

PMID: 40046804 PMC: 11878815. DOI: 10.56305/001c.38580.

Pathogenic variants in the Alport genes are prevalent in the Singapore multiethnic population with highest frequency in the Chinese.

Lim T, Koh C, Savige J, Ng A, Ng J, Chin H Sci Rep. 2025; 15(1):7691.

PMID: 40044766 PMC: 11883019. DOI: 10.1038/s41598-025-92520-9.

Next-generation nephrology: part 2-mainstreaming genomics in nephrology, a global perspective.

Gupta A, Jayasinghe K, Majmundar A, Mann N, Sinha R, Sampson M Pediatr Nephrol. 2025; .

PMID: 40019555 DOI: 10.1007/s00467-025-06711-7.

Candidate Genetic Modifiers in Alport Syndrome: A Case Series.

Lujinschi S, Sorohan B, Obrisca B, Vrabie A, Rusu E, Zilisteanu D Life (Basel). 2025; 15(2).

PMID: 40003707 PMC: 11857524. DOI: 10.3390/life15020298.

References

McClellan W, Satko S, Gladstone E, Krisher J, Narva A, Freedman B . Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities. Am J Kidney Dis. 2009; 53(3 Suppl 3):S100-6. DOI: 10.1053/j.ajkd.2008.07.059. View

Fellstrom B, Jardine A, Schmieder R, Holdaas H, Bannister K, Beutler J . Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009; 360(14):1395-407. DOI: 10.1056/NEJMoa0810177. View

Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A . Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet. 2010; 128(3):345-50. PMC: 2921485. DOI: 10.1007/s00439-010-0861-0. View

Genovese G, Friedman D, Ross M, Lecordier L, Uzureau P, Freedman B . Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010; 329(5993):841-5. PMC: 2980843. DOI: 10.1126/science.1193032. View

Harambat J, van Stralen K, Kim J, Tizard E . Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2011; 27(3):363-73. PMC: 3264851. DOI: 10.1007/s00467-011-1939-1. View

Dixon-Salazar T, Silhavy J, Udpa N, Schroth J, Bielas S, Schaffer A . Exome sequencing can improve diagnosis and alter patient management. Sci Transl Med. 2012; 4(138):138ra78. PMC: 4442637. DOI: 10.1126/scitranslmed.3003544. View

Sanna-Cherchi S, Kiryluk K, Burgess K, Bodria M, Sampson M, Hadley D . Copy-number disorders are a common cause of congenital kidney malformations. Am J Hum Genet. 2012; 91(6):987-97. PMC: 3516596. DOI: 10.1016/j.ajhg.2012.10.007. View

Liapis H, Gaut J . The renal biopsy in the genomic era. Pediatr Nephrol. 2012; 28(8):1207-19. DOI: 10.1007/s00467-012-2356-9. View

Yang Y, Muzny D, Reid J, Bainbridge M, Willis A, Ward P . Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013; 369(16):1502-11. PMC: 4211433. DOI: 10.1056/NEJMoa1306555. View

10.

Inrig J, Califf R, Tasneem A, Vegunta R, Molina C, Stanifer J . The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov. Am J Kidney Dis. 2013; 63(5):771-80. PMC: 3988265. DOI: 10.1053/j.ajkd.2013.10.043. View

11.

Devuyst O, Knoers N, Remuzzi G, Schaefer F . Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet. 2014; 383(9931):1844-59. PMC: 4135047. DOI: 10.1016/S0140-6736(14)60659-0. View

12.

Wuhl E, van Stralen K, Wanner C, Ariceta G, Heaf J, Bjerre A . Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry. Nephrol Dial Transplant. 2014; 29 Suppl 4:iv1-8. DOI: 10.1093/ndt/gfu030. View

13.

Lee H, Deignan J, Dorrani N, Strom S, Kantarci S, Quintero-Rivera F . Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014; 312(18):1880-7. PMC: 4278636. DOI: 10.1001/jama.2014.14604. View

14.

Farwell K, Shahmirzadi L, El-Khechen D, Powis Z, Chao E, Davis B . Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genet Med. 2014; 17(7):578-86. DOI: 10.1038/gim.2014.154. View

15.

Amendola L, Dorschner M, Robertson P, Salama J, Hart R, Shirts B . Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 2015; 25(3):305-15. PMC: 4352885. DOI: 10.1101/gr.183483.114. View

16.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

17.

Connaughton D, Bukhari S, Cassidy E, OToole M, Mohamad M, Flanagan J . The Irish Kidney Gene Project--Prevalence of Family History in Patients with Kidney Disease in Ireland. Nephron. 2015; 130(4):293-301. DOI: 10.1159/000436983. View

18.

Olfson E, Cottrell C, Davidson N, Gurnett C, Heusel J, Stitziel N . Identification of Medically Actionable Secondary Findings in the 1000 Genomes. PLoS One. 2015; 10(9):e0135193. PMC: 4558085. DOI: 10.1371/journal.pone.0135193. View

19.

Floege J, Mak R, Molitoris B, Remuzzi G, Ronco P . Nephrology research--the past, present and future. Nat Rev Nephrol. 2015; 11(11):677-87. DOI: 10.1038/nrneph.2015.152. View

20.

Canetta P, Radhakrishnan J . The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome. Front Pediatr. 2015; 3:78. PMC: 4585181. DOI: 10.3389/fped.2015.00078. View